Suppr超能文献

糖基化 HIV 天然样包膜三聚体 TLR 激动剂缀合物可保持中和表位。

Conjugation of a Toll-Like Receptor Agonist to Glycans of an HIV Native-Like Envelope Trimer Preserves Neutralization Epitopes.

机构信息

Department of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG, Utrecht, The Netherlands.

Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, 1105AZ, Amsterdam, The Netherlands.

出版信息

Chembiochem. 2022 Aug 17;23(16):e202200236. doi: 10.1002/cbic.202200236. Epub 2022 Jun 20.

Abstract

Small molecule adjuvants are attractive for enhancing broad protection and durability of immune responses elicited by subunit vaccines. Covalent attachment of an adjuvant to an immunogen is particularly attractive because it simultaneously delivers both entities to antigen presenting cells resulting in more efficient immune activation. There is, however, a lack of methods to conjugate small molecule immune potentiators to viral glycoprotein immunogens without compromising epitope integrity. We describe herein a one-step enzymatic conjugation approach for the covalent attachment of small molecule adjuvants to N-linked glycans of viral glycoproteins. It involves the attachment of an immune potentiator to CMP-Neu5AcN by Cu(I)-catalyzed azide-alkyne 1,3-cycloaddition followed by sialyltransferase-mediated transfer to N-glycans of a viral glycoprotein. The method was employed to modify a native-like HIV envelope trimer with a Toll-like receptor 7/8 agonist. The modification did not compromise Env-trimer recognition by several broadly neutralization antibodies. Electron microscopy confirmed structural integrity of the modified immunogen.

摘要

小分子佐剂在增强亚单位疫苗引起的广泛保护和耐久性方面具有吸引力。将佐剂共价连接到免疫原上特别有吸引力,因为它同时将两者递送到抗原呈递细胞,从而更有效地激活免疫。然而,缺乏将小分子免疫增强剂与病毒糖蛋白免疫原缀合而不损害表位完整性的方法。本文描述了一种一步酶促偶联方法,用于将小分子佐剂共价连接到病毒糖蛋白的 N 连接糖上。它涉及通过 Cu(I)催化的叠氮化物-炔烃 1,3-环加成将免疫增强剂附着到 CMP-Neu5AcN 上,然后通过唾液酸转移酶介导转移到病毒糖蛋白的 N-糖上。该方法用于用 Toll 样受体 7/8 激动剂修饰天然样 HIV 包膜三聚体。修饰不会损害几种广泛中和抗体对 Env-三聚体的识别。电子显微镜证实了修饰后的免疫原的结构完整性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efca/9546345/8b2eabb7ce61/CBIC-23-0-g005.jpg

相似文献

1
Conjugation of a Toll-Like Receptor Agonist to Glycans of an HIV Native-Like Envelope Trimer Preserves Neutralization Epitopes.
Chembiochem. 2022 Aug 17;23(16):e202200236. doi: 10.1002/cbic.202200236. Epub 2022 Jun 20.
2
Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers .
J Virol. 2018 Jun 13;92(13). doi: 10.1128/JVI.00381-18. Print 2018 Jul 1.
4
Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
J Virol. 2015 Oct;89(20):10383-98. doi: 10.1128/JVI.01653-15. Epub 2015 Aug 5.
9
Design and characterization of a germ-line targeting soluble, native-like, trimeric HIV-1 Env lacking key glycans from the V1V2-loop.
Biochim Biophys Acta Gen Subj. 2021 Jan;1865(1):129733. doi: 10.1016/j.bbagen.2020.129733. Epub 2020 Sep 16.

本文引用的文献

1
Emerging concepts in the science of vaccine adjuvants.
Nat Rev Drug Discov. 2021 Jun;20(6):454-475. doi: 10.1038/s41573-021-00163-y. Epub 2021 Apr 6.
2
Self-Adjuvanting Cancer Vaccines from Conjugation-Ready Lipid A Analogues and Synthetic Long Peptides.
J Med Chem. 2020 Oct 22;63(20):11691-11706. doi: 10.1021/acs.jmedchem.0c00851. Epub 2020 Oct 6.
4
Site-specific glycan analysis of the SARS-CoV-2 spike.
Science. 2020 Jul 17;369(6501):330-333. doi: 10.1126/science.abb9983. Epub 2020 May 4.
6
Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen.
Cell Rep. 2018 Aug 21;24(8):1958-1966.e5. doi: 10.1016/j.celrep.2018.07.080.
7
Metabolic labeling of HIV-1 envelope glycoprotein gp120 to elucidate the effect of gp120 glycosylation on antigen uptake.
J Biol Chem. 2018 Sep 28;293(39):15178-15194. doi: 10.1074/jbc.RA118.004798. Epub 2018 Aug 16.
8
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure.
Immunity. 2018 May 15;48(5):855-871. doi: 10.1016/j.immuni.2018.04.029.
9
Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation.
PLoS Pathog. 2018 May 2;14(5):e1007024. doi: 10.1371/journal.ppat.1007024. eCollection 2018 May.
10
Toll-like Receptor Agonist Conjugation: A Chemical Perspective.
Bioconjug Chem. 2018 Mar 21;29(3):587-603. doi: 10.1021/acs.bioconjchem.7b00808. Epub 2018 Feb 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验